ESTERO, FL / ACCESSWIRE / October 19, 2023 / Mushrooms Inc., (OTC PINK:MSRM) provides further insights into its recently filed patent, "METHOD OF GENERATING MULTIFUNCTIONAL MYCELIUM PRODUCTS." This groundbreaking patent not only emphasizes bacterial detection but also spotlights a transformative approach to nutrient delivery in textiles. This release specifically addresses the potential of nutrient delivery in textile development which they call MYCOThread, and also rectifies the U.S. Patent Application No. to 18/488,639, as previously misstated.
Kimberly Carlson, CEO of MSRM, remarked, "Yesterday we highlighted our product's bacterial detection capabilities. Today, we're excited to shed light on its potential in textile innovation. We have set up phases for the development of the MYCOthread with an emphasis on speed to market and revenue generation, supporting extensive testing for our flagship technology. We're starting with biodegradable thread for fabric and advancing to adaptogenic, nutrient-rich textiles with transdermal delivery. Specific applications are aimed towards athletic wear that aids recovery and reduces cramps, bedsheets that optimize relaxation and every-day wear that delivers custom health catered to individual needs."
Board Director, Donald Steinberg, describes the technology this way, "Historically, studies have shown that our bodies can absorb substances from our clothing, as seen with the toxic chemical fire-retardants in children's pajamas. We're harnessing this absorption capability positively by combining mycelium's characteristics and advanced technology to deliver beneficial nutrients consistently."
Amid the innovative pursuits, it's essential to underscore the company's robust foundation. Mushrooms Inc. has consistently demonstrated a deep-rooted commitment to scientific rigor, technological advancement, and market-driven innovation. With a seasoned team of professionals, the company is not only advancing the frontier of mycelium research but also ensuring that each development is grounded in real-world applications and scalability. It's this blend of visionary thinking and pragmatic execution that sets Mushrooms Inc. apart. This full patent filing, is an example of how they meet the goals they have set out to attain and take them beyond what was originally expected.
Mushrooms Inc's full patent filing centers around methods that generate multifunctional mycelium products capable of bacterial detection and nutrient delivery. With applications spanning healthcare, aerospace, lifestyle, and more, this technology is set to make significant inroads across various industries.
The newly filed patent, under the patent number 18/488,639, stands independent of the provisional patent, embodying the collective intelligence and innovative contributions of four esteemed inventors: Kimberly Carlson, Dr. Hyder Ali Khoja, Maqsad Suriev, and Donald Steinberg.
Mushrooms Inc extends its gratitude to its dedicated team, partners, and supporters. Their commitment to innovation, combined with a relentless pursuit of excellence, has positioned the company at the forefront of mycelium technology development.
About Mushrooms Inc.
Mushrooms Inc. (OTC PINK:MSRM) is a publicly traded company on the OTC Markets with the stock symbol MSRM and is the first industrial mushroom company to be listed on a public exchange. Mushrooms Inc. is a pioneering biotech company, deeply entrenched in the world of mycology. Our primary mission is to harness the transformative potential of Mycelium, especially for groundbreaking applications in the healthcare sector. Our dedicated R&D endeavors are underpinned by advanced technology, ensuring rigorous testing and validation of the manifold health benefits of mushrooms, thereby leading to the formulation of scientifically-backed supplements.
Our recent patent underscores our innovation-driven ethos, detailing novel methods for bacterial detection and nutrient delivery using mycelium. This patent stands as a testament to our commitment to intertwining age-old wisdom with contemporary technological advancements, aiming to revolutionize healthcare interventions and amplify overall well-being.
Inspired by the vision and resilience of mycology pioneers, Mushrooms Inc. establishes robust partnerships, resulting in products that champion both human health and environmental sustainability.
Prior Press Releases
- Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery
- Announces Diverse Business Development Team Assembled to Drive Company Growth
- Poised for Textile Innovation and Global Impact as Full Patent Filing for Mycelium Thread Nears Completion
- CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast
- Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders
- Mushrooms, Inc. Announces Name and Ticker Symbol Change on O_T_C_ _M_a_r_k_e_t_s_ _t_o_ _"M_S_R_M_" _
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such
expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
Corporate Contact:
CEO: Kimberly Carlson
Tel: (877) 379-5400
email: [email protected]
www.mushroomsinc.com
SOURCE: Mushrooms, Inc.